Antibody production
-
Antibody production
Can a single amino acid mutation change the course of the COVID-19 pandemic?
Viruses mutate in the course of an epidemic as a result of selective pressure or genetic drift. Resulting mutations may result in enhanced fitness or better efficiencies in evading the…
-
Essential antibody library generation and display technologies for the discovery of new reagents and biopharmaceuticals
Library generation is a vital first step in any antibody phage display project for therapeutic applications and others. Libraries… Read More
-
Can successful anticancer immunotherapies change the course of the COVID-19 disease?
A recent study revealed the hidden parallelisms in our organism’s response to cancer and COVID-19. Despite the marked differences between… Read More
-
Why phage display for monoclonal antibody production remains an unrivaled technology
Phage display technology revolutionized antibody discovery. By coupling the structural simplicity of phages with the fast replication and high turnover… Read More
-
How to leverage recombinant monoclonal antibody production to increase clinical success rates
Ever since the onset of recombinant technology, therapeutic biologics production has gradually shifted from native to recombinant expression. Today, recombinant… Read More
-
Fundamental and advanced methods to improve monoclonal antibody production in vitro
Ever since the discovery of the hybridoma technology and its inherent limitations, monoclonal antibody production has gradually shifted from hybridoma-based… Read More
-
Will a single COVID-19 drug be enough to treat all patients?
As more and more biotherapeutics enter the early stages of clinical development, scientists are questioning if current approaches will be… Read More
-
Will camelid antibodies offer a solution to solve the COVID-19 pandemic?
The emergence of the zoonotic pathogen, SARS-CoV-2, resulted in a global pandemic and caused the deaths of hundreds of thousands… Read More
-
What are chimeric antibodies?
Considered by many researchers as intermediate molecules, chimeric antibody constructs have been gradually losing ground to more effective molecules such… Read More
-
Fully human antibodies that will make the news in 2020
As the demand for fully human antibodies continues to rise, so does the proportion of clinical approvals of this type… Read More